Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 12 record(s)

Req # A-2022-05126

Provide all emails with keyword “ATIP” from May 1, 2021 to February 23, 2022.

Organization: Patented Medicine Prices Review Board Canada

606 page(s)
April 2023

Req # A-2021-24940

Provide all emails sent to/from Tanya Potashnik from May 1, 2021, to December 19, 2021. Exclude media scans.

Organization: Patented Medicine Prices Review Board Canada

1186 page(s)
April 2023

Req # A-2021-00056

Briefing Note: 774224 FINTRAC’s Effectiveness Update for the 4th Follow-up Report of Canada to the Financial Action Task Force (FATF);

Organization: Financial Transactions and Reports Analysis Centre of Canada

2 page(s)
April 2022

Req # A-2021-00058

Briefing Note: 767605 FINTRAC’s Input to the Follow-up Report of Canada to the Financial Action Task Force (FATF) ;

Organization: Financial Transactions and Reports Analysis Centre of Canada

3 page(s)
April 2022

Req # A-2021-00076

Obtain a copy of all the official correspondences/letters emails on everything pertaining to the application/administration of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act, including the attached documents, sent or received by Sarah Paquet in her function of Director and Chief Executive Officer (CEO) of CANAFE for the period between July 1, 2021, and November 14, 2021, for the following category: Communication with the Department of Finance Canada

Organization: Financial Transactions and Reports Analysis Centre of Canada

13 page(s)
April 2022

Req # A-2021-10765

Copies of all expense claims and receipts over $ 100.00 for Douglas Clark, Tanya Potashnik and Mitchell Levine. For each expense provide the name of the service provider/contractor, a description of the product or service rendered, the date, and the total amount of the expense. When those three items can not be provided in said format, provide the entirety of records (including receipts, purchase orders, and service contracts) pertaining to the expense.

Organization: Patented Medicine Prices Review Board Canada

158 page(s)
April 2022

Req # A-2021-10768

Copies of all communications between the PMPRB and Health Canada from May 22, 2021 to June 11, 2021.

Organization: Patented Medicine Prices Review Board Canada

53 page(s)
April 2022

Req # A-2021-10771

Copies of all emails or logs of media requests or contacts with the PMPRB and Douglas Clark between May 22, 2021 to June 11, 2021.

Organization: Patented Medicine Prices Review Board Canada

11 page(s)
April 2022

Req # A-2020-03991

Copies of all records, analysis, correspondence, discussions, briefings, memos and decisions, about the development of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, and EX-all levels. Also include the Minister and Political staff; between January 2016 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

478 page(s)
April 2021

Req # A-2020-03992

Copies of all analysis, correspondence, discussions, briefings and memos about the evaluation of stakeholder submissions for the PMPRB regulations (including submissions relating to the 2016 PMPRB guidelines modernization, the 2017 consultations on potential changes to the PMPRB regulations, Canada Gazette Part I, and Canada Gazette Part II) involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all levels. Include the Minister and Political staff; between January 2016 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

323 page(s)
April 2021
Date modified: